The Journal of Allergy and Clinical Immunology
Volume 120, Issue 2 , Pages 263-270 , August 2007

Advances in basic and clinical immunology in 2006

  • Javier Chinen, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Javier Chinen, MD, PhD, Department of Pediatrics, Allergy and Immunology Section, Baylor College of Medicine, Texas Children's Hospital, 1102 Bates St, Houston, TX 77030.
    • ,
  • William T. Shearer, MD, PhD

Received 17 May 2007 ,Accepted 22 May 2007.

References 

  1. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979–987
  2. Schaub B, Lauener R, von Mutius E. The many faces of the hygiene hypothesis. J Allergy Clin Immunol. 2006;117:969–977
  3. Liu AH, Leung DYM. Renaissance of the hygiene hypothesis. J Allergy Clin Immunol. 2006;117:1063–1069
  4. Horner AA. Toll-like receptor ligands and atopy: a coin with at least two sides. J Allergy Clin Immunol. 2006;117:1133–1140
  5. Taylor RC, Richmond P, Upham JW. Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. J Allergy Clin Immunol. 2006;117:1148–1154
  6. Hoarau C, Lagaraine C, Martin L, Velge-Roussel F, Lebranchu Y. Supernatant of Bifidobacterium breve induces dencritic cell maturation, activation and survival through a Toll-like receptor 2 pathway. J Allergy Clin Immunol. 2006;117:696–702
  7. Fili L, Ferri S, Guarna F, Sampognaro S, Manuelli C, Liotta F, et al. Redirection of allergen-specific TH2 responses by a modified adenine through Toll-like receptor 7 interaction and IL12/IFN release. J Allergy Clin Immunol. 2006;118:511–518
  8. Thivierge M, Stankova J, Rola Plaesczynski M. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells. J Allergy Clin Immunol. 2006;117:1155–1162
  9. McDonald DR, Brown D, Bonilla FA, Geha RS. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses. J Allergy Clin Immunol. 2006;118:1357–1362
  10. Sudowe S, Portugal IL, Montermann E, Ross R, Reske-Kunz AB. Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells. J Allergy Clin Immunol. 2006;117:196–203
  11. Gablez M, Schelblhofer S, Kern K, Leitner WW, Stoecklinger A, Hauser-Kronberger C, et al. Immunization with a low-dose replicon DNA vaccine encoding Phl p5 effectively prevents allergic sensitization. J Allergy Clin Immunol. 2006;118:734–741
  12. Bauer R, Scheliblhofer S, Kern K, Gruber C, Stepanoska T, Thalhamer T, et al. Generation of hypoallergenic DNA vaccines by forced ubiquitination: preventive and therapeutic effects in a mouse model of allergy. J Allergy Clin Immunol. 2006;118:269–276
  13. Higgins D, Rodriguez R, Milley R, Marshall J, Abbate C, dela Cruz T, et al. Modulation of immunogenicity and allergenicity by controlling the number of immunostimulatory oligonucleotides linked to Amb a 1. J Allergy Clin Immunol. 2006;118:504–510
  14. Kundig TM, Santi G, Schnetzler G, Wolf C, Vavricka BMP, Fulurija A, et al. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol. 2006;117:1470–1476
  15. Seidel-Guyenot W, Perschon S, Dechant N, Alt R, Knop J, Steinbrick K. Low zone tolerance induced by systemic application of allergens inhibits Tc1-mediated skin inflammation. J Allergy Clin Immunol. 2006;117:1170–1177
  16. Russano AM, Agea E, Corazzi L, Postle AD, De Libero G, Porcelli S, et al. Recognition of pollen-derived phosphatidyl-ethanolamine by human CD1d restricted gd T cells. J Allergy Clin Immunol. 2006;117:1178–1184
  17. Elkhal A, Pichavant M, He R, Scott J, Meyer E, Goya S, et al. CD1d restricted natural killer T cells are not required for allergic skin inflammation. J Allergy Clin Immunol. 2006;118:1363–1368
  18. Pham-Thi N, deBlic J, LeBourgeois M, Dy M, Scheinmann P, Leite-de-Moraes MC. Enhanced frequency of immunoregulatory invariant natural killer T cells in the airways of children with asthma. J Allergy Clin Immunol. 2006;117:217–218
  19. KleinJan A, Wilart M, van Rijt L, Braunstahl GJ, Leman K, Jung S, et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol. 2006;118:1117–1125
  20. Polte T, Behrendt AK, Hansen G. Direct evidence for a critical role of CD30 in the development of allergic asthma. J Allergy Clin Immunol. 2006;118:942–948
  21. Aoi N, Masuda T, Murakami D, Yajima T, Mizubuchi H, Yamada H, et al. IL-15 prevents allergic rhinitis through reactivation of antigen-specific CD8+ cells. J Allergy Clin Immunol. 2006;117:1359–1366
  22. Yakindag A, He R, Laouini D, Alerius M, Carroll M, Oettgen HC, et al. The complement component C3 plays a critical role in both TH1 and TH2 responses to antigen. J Allergy Clin Immunol. 2006;117:1455–1461
  23. Grinnan D, Sung SS, Dougherty JA, Knowles AR, Allen MB, Rose CE, et al. Enhanced allergen-induced airway inflammation in paucity of lymph node T cell (plt) mutant mice. J Allergy Clin Immunol. 2006;118:1234–1241
  24. Lamoreaux J, Stankova J, Roda-Plesaczynski . Leukotriene D4 enhances immunoglobulin production in CD40-activated human B lymphocytes. J Allergy Clin Immunol. 2006;117:924–930
  25. Trudeau J, Hu H, Chibana K, Chu HW, Westcott JY, Wenzel SE. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol. 2006;117:1446–1454
  26. Gold DR, Willworth BM, Tantisira KG, Finn PW, Schaub B, Perkins DL, et al. Associations of cord blood fatty acids with lymphocyte proliferation, IL-13, and IFN-g. J Allergy Clin Immunol. 2006;117:931–938
  27. Liu SM, Xavier R, Good KL, Chtanova T, Newton R, Sisavanh M, et al. Immune cell transcriptome datasets reveal novel leukocyte subset-specific genes and genes associated with allergic processes. J Allergy Clin Immunol. 2006;118:496–503
  28. Kamchaisatian W, Wanwatsuntikul W, Sleasman JW, Tangalnmankong N. Validation of current joint American Academy of Allergy, Asthma and Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol. 2006;118:1336–1341
  29. Uekert SJ, Akan G, Evans MD, Li Z, Roberg K, Tisler C, et al. Sex-related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol. 2006;118:1375–1381
  30. Allakhverdi Z, Fitzpatrick D, Bolsvert A, Baba N, Boughermouh S, Sarfati M, et al. Expression of CD103 identifies human regulatory T-cell subsets. J Allergy Clin Immunol. 2006;118:1342–1349
  31. Nahm DH, Lee KH, Shin JY, Ye YM, Kang Y, Park HS. Identification of a-enolase as an autoantigen associated with severe asthma. J Allergy Clin Immunol. 2006;118:376–381
  32. Bateman EAL, Ardern-Jones MR, Ogg GS. Persistent central memory phenotype of circulating Fel d1 peptide/DRB1∗0101 tetramer-binding CD4+ T cells. J Allergy Clin Immunol. 2006;118:1350–1356
  33. Ballow M. Biologic immune modifiers: trials and tribulations: are we there yet?. J Allergy Clin Immunol. 2006;118:1209–1215
  34. Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol. 2006;117:883–896
  35. Garcia-Laorden MI, Garcia-Saavedra A, RodriguezdeCastro F, Violan J, Rojas O, Blanquer J. Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency. J Allergy Clin Immunol. 2006;118:1384–1387
  36. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol. 2006;117:740–746
  37. Berglund LJ, Jones GJ, Murali R, Fulcher DA. TACI mutation with invasive CD8 T-cell lymphoproliferation in a patient with common variable immunodeficiency. J Allergy Clin Immunol. 2006;117:870–877
  38. Lin JH, Liebhaber M, Roberts RL, Dyer Z, Stiehm ER. Etarnecept treatment of cutaneous granulomas in common variable immunodeficiency. J Allergy Clin Immunol. 2006;117:878–882
  39. Notarangelo LD, Lanzi G, Peron S, Durandy A. Defects of class-switch recombination. J Allergy Clin Immmunol. 2006;117:855–864
  40. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117:725–738
  41. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: A review of evidence by member of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2006;117:S525–S553
  42. Lavi RF, Kamchaisatian W, Sleasman JW, Martin DP, Haraguchi S, Day NK, et al. Thymic output markers indicate immune dysfunction in DiGeorge syndrome. J Allergy Clin Immunol. 2006;118:1184–1186
  43. Roifman CM, Gu Y, Cohen A. Mutations in the RNA component of mitochondria RNAse processing might cause Omenn's syndrome. J Allergy Clin Immunol. 2006;117:897–903
  44. Cac NN, Ballas ZK. Recalcitrant warts, associated with natural killer dysfunction, treated with systemic IFN-a. J Allergy Clin Immunol. 2006;118:526–528
  45. Beeler A, Engler O, Gerber BO, Pichler WJ. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol. 2006;117:455–462
  46. Wu Y, Sanderson JP, Farrell J, Drummond NS, Hanson A, Bowkett E, et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol. 2006;118:233–241
  47. Rodriguez-Pena R, Lopez S, Mayorga C, Antunez C, Fernandez TD, Torres MJ, et al. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to b-lactams. J Allergy Clin Immunol. 2006;118:949–956
  48. Blanch A, Roche O, Urrutia I, Gamboa P, Fontan G, Lopez-Trascasa M. First case of homozygous C1 inhibitor deficiency. J Allergy Clin Immunol. 2006;118:1330–1335
  49. Frank MM, Atkinson A. Homozygous C1 inhibitor deficiency: the conclusion of a long search. J Allergy Clin Immunol. 2006;118:1327–1329
  50. Levi M, Choi G, Picavet C, Hack E. Self-administration of C1-inhibitor concentrate in patients with hereditary angioedema caused by C1-inhibitor deficiency. J Allergy Clin Immunol. 2006;117:870–877
  51. Caballero T, Lopez-Serrano C. Anaphylactic reaction and antibodies to DX-88 (kalikrein inhibitor) in a patient with hereditary angioedema. J Allergy Clin Immunol. 2006;117:476
  52. Feeney ME, Tang Y, Rathod A, Knout C, McIntosh K. Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy. J Allergy Clin Immunol. 2006;118:324–330
  53. Saitoh A, Singh KK, Sandall S, Powell CA, Fenton T, Fletcher CV, et al. Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy. J Allergy Clin Immunol. 2006;117:909–915
  54. Shearer WT, Deville JG, Samson PM, Moye JH, Fletcher CV, Church JA, et al. Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140). J Allergy Clin Immunol. 2006;118:518–521
  55. Williamson MP, McCormick TG, Nance CL, Shearer WT. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J Allergy Clin Immunol. 2006;118:1369–1374
  56. Parrino J, Graham BS. Smallpox vaccines: past, present, and future. J Allergy Clin Immunol. 2006;118:1320–1326
  57. Glezen WP. Asthma, influenza and vaccination. J Allergy Clin Immunol. 2006;118:1199–1206
  58. Kancherla VS, Hanson CI. Mumps resurgence in the United States. J Allergy Clin Immunol. 2006;118:938–941
  59. Cardona ID, Goleva E, Ou LS, Leung DYM. Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. J Allergy Clin Immunol. 2006;117:688–695
  60. Mandron M, Aries MF, Brehm RD, Tranter HS, Acharya R, Charveron M, et al. Human dendritic cells conditioned with Staphylococcus aureus enterotoxin B promote TH2 polarization. J Allergy Clin Immunol. 2006;17:1141–1147
  61. Hartl D, Griese M, Kappler M, Zissel G, Reinhardt D, Rebhan C, et al. Pulmonary TH2 response in Pseudomonas aeruginosa-infected patients with cystic fibrosis. J Allergy Clin Immunol. 2006;117:204–211
  62. Saadane A, Soltys J, Berger M. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kB activation, cytokine secretion and persistent lung inflammation. J Allergy Clin Immunol. 2006;117:1163–1169
  63. Antas PRZ, Ding L, Heckman J, Reeves-Hammock L, Shintani AK, Schiffer J, et al. Decreased CD4+ lymphocytes and innate immune responses in adults with previous extrapulmonary tuberculosis. J Allergy Clin Immunol. 2006;117:916–923
  64. Fuller CL, Brittingham KC, Hepburn MJ, Martin JW, Pettit PL, Pittman PR, et al. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination. J Allergy Clin Immunol. 2006;117:1186–1188
  65. Mitre E, Nutman TB. IgE memory: persistence of antigen-specific IgE responses years after treatment of human filarial infections. J Allergy Clin Immunol. 2006;117:930–945

 Supported by National Institutes of Health grants AI269441, AI36211, HD52102, RR0188, HD079533, HL72705, HD78522, and RAT003084A and contract AI41089; the Pediatric Research and Education Fund, Baylor College of Medicine; and the David Fund, Pediatrics AIDS Fund, and Immunology Research Fund, Texas Children's Hospital.Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(07)01026-3

doi: 10.1016/j.jaci.2007.05.031

The Journal of Allergy and Clinical Immunology
Volume 120, Issue 2 , Pages 263-270 , August 2007

Article Tools

* Image Usage & Resolution